Last week, GenomeQuest held our "The Next Generation of Sequence Analysis" seminar for Harvard-based Researchers. It was sponsored by Bob Steen, manager of the Harvard Biopolymers Facility. According to Bob, it was the 2nd largest crowd ever for his seminars and the largest ever for a software topic -- an indicator that reseachers ...
The provocative title The Debt Crisis and the Human Genome belies Mike Mandels underlying message. I do worry that articles like this and the recent NY Times article A Decade Later, Human Genome Project Yields Few New Cures feed the cynics. Our society is so enamored with immediate gratification. Rome wasn't built in ...
This week, I attended the Consumer Genomics Show (more so a “clinical genomics" show). In a session on Next Generation Sequencing led by five industry experts, a recurring observation was that, on the one hand, steady investments in sequencing technology was indeed delivering breathtaking value and driving down sequencing costs – bravo indeed and ...